Treatment of DNA viral infections

Details Treatment of DNA viral infections Treatment of DNA viral infections

2005-05-17

2005-05-17

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S025000, C514S027000, C514S033000, C514S034000, C514S461000, C514S471000

Reexamination Certificate

active

06894030

ABSTRACT:
The synergistic combination of a loop diuretic and a cardiac glycoside is useful in the treatment of DNA viral infections.

REFERENCES:
patent: 20020019443 (2002-02-01), Campbell
patent: 442744 (1991-08-01), None
patent: 0 442 744 (1991-08-01), None
patent: WO 0010574 (2000-03-01), None
Manunta et al., “Structure-Activity Relationships for the Hypertensinogenic Activity of Ouabain”, Hypertension, 37[part 2], pp. 472-477, 2001.*
T.G. Voss, “Reduction of Human Immunodeficiency Virus Production and Cytopathiceffects by Inhibitors of the NA+/K+/Cl—Cotransporter”, Virology, Academic Press, Orlando, US, vol. 219, No. 249, 1996, pp. 291-294, XP002925373, ISSN: 0042-6822.

Affiliated with

Also associated with

Rating

Treatment of DNA viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of DNA viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of DNA viral infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3373246